Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation

被引:51
作者
Blanc, JJ
Voinov, C
Maarek, M
机构
[1] Brest Univ Hosp, Dept Cardiol, Brest, France
[2] Med Dept Labs, Knoll, France
关键词
D O I
10.1016/S0002-9149(99)00493-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with recent-onset atrial fibrillation (AF), restoration of sinus rhythm is considered to be the First-line therapeutic option, Although this conversion might be obtained by direct-current shock or intravenous antiar- rhythmic drugs, administration of an oral loading dose of class I or III antiarrhythmic drugs is more simple and convenient. This prospective, randomized, multicenter study compares the time to conversion to sinus rhythm obtained with an oral loading dose of propafenone or amiodarone, Patients with recent-onset AF (<2 weeks), without contraindications for the 2 drugs, were randomly assigned to be treated with propafenone (600 mg for the first 24 hours and if necessary a repeated dose of 300 mg for 24 hours) or amiodarone (30 mg/kg for the first 24 hours and if necessary a repeated dose of 15 mg/kg for 24 hours). Exact conversion time during the first 24 hours was determined by Holter monitoring. In each treatment group 43 patients with the same baseline characteristics were included, The median time for restoration of sinus rhythm was shelter (p = 0.05) in the propafenone (2.4 hours) than in the amiodarone (6.9 hours) group, After 24 hours (56% in the propofenone and 47% in the amiodarone group) and 48 hours, the same proportion of patients in the 2 groups recovered sinus rhythm (no serious adverse events were noticed). Thus, oral loading dose of propafenone or amiodarone was safe with a similar conversion rate of recent-onset AF, Propofenone had a faster action, (C) 1999 by Excerpta Medico, Inc.
引用
收藏
页码:1029 / 1032
页数:4
相关论文
共 28 条
  • [21] Management of patients with atrial fibrillation - A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association
    Prystowsky, EN
    Benson, DW
    Fuster, V
    Hart, RG
    Kay, GN
    Myerburg, RJ
    Naccarelli, GV
    Wyse, DG
    [J]. CIRCULATION, 1996, 93 (06) : 1262 - 1277
  • [22] ROBERTSON CE, 1980, BRIT HEART J, V44, P602
  • [23] CLINICAL EFFICACY OF AMIODARONE AS AN ANTIARRHYTHMIC AGENT
    ROSENBAUM, MB
    CHIALE, PA
    HALPERN, MS
    NAU, GJ
    PRZYBYLSKI, J
    LEVI, RJ
    LAZZARI, JO
    ELIZARI, MV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1976, 38 (07) : 934 - 944
  • [24] THE VALUE OF CLASS-IC ANTIARRHYTHMIC DRUGS FOR ACUTE CONVERSION OF PAROXYSMAL ATRIAL-FIBRILLATION OR FLUTTER TO SINUS RHYTHM
    SUTTORP, MJ
    KINGMA, JH
    JESSURUN, ER
    LIEAHUEN, L
    VANHEMEL, NM
    LIE, KI
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (07) : 1722 - 1727
  • [25] REGULAR VENTRICULAR RHYTHMS IN PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION
    WEINER, HL
    MCCARTHY, EA
    PRITCHETT, ELC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (06) : 1283 - 1287
  • [26] CLINICAL COURSE OF RECENT-ONSET ATRIAL-FIBRILLATION TREATED WITH ORAL PROPAFENONE
    WEINER, P
    GANAM, R
    GANEM, R
    ZIDAN, F
    RABNER, M
    [J]. CHEST, 1994, 105 (04) : 1013 - 1016
  • [27] ATRIAL-FIBRILLATION BEGETS ATRIAL-FIBRILLATION - A STUDY IN AWAKE CHRONICALLY INSTRUMENTED GOATS
    WIJFFELS, MCEF
    KIRCHHOF, CJHJ
    DORLAND, R
    ALLESSIE, MA
    [J]. CIRCULATION, 1995, 92 (07) : 1954 - 1968
  • [28] EFFECTS OF AMIODARONE VERSUS QUINIDINE AND VERAPAMIL IN PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION - RESULTS OF A COMPARATIVE-STUDY AND A 2-YEAR FOLLOW-UP
    ZEHENDER, M
    HOHNLOSER, S
    MULLER, B
    MEINERTZ, T
    JUST, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) : 1054 - 1059